$IRMD #Stocks #StockMarket #Iradimed reported Q1 EPS on https://t.co/savSNTKlN1: Sales growth of 2.844 %, could not prevent EPS contraction of -6.67 % in the Q1, compared to same quarter a year ago. Sales were at $8.678 MM and eps at $0.14. https://t.co/HAcZqI550y